NCT01298271View on ClinicalTrials.gov

A Randomized Trial of GVS Alone vs. Propranolol

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Bleeding Gastric VaricesLiver Cirrhosis
Interventions
DRUG

propranolol

Starting from 20 mg daily, titrated weekly to decrease heart rate more than 25 % of baseline, administrated during the whole study period

Trial Locations (1)

11217

RECRUITING

Veteran General Hospital-Taipei, Taipei

All Listed Sponsors
lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV